NEW YORK, August 10, 2022 /PRNewswire/ — GLO Pharma, the parent company of groundbreaking subtopic skincare brand Ourself, today announces the appointment of Dayna Quanbeck to its board of directors. Rothy’s CFO will join the board effective immediately, and her appointment adds a new seat to the GL Pharmaceutical Council, which is headed by the President Scott L. Glenn. GLO Pharma’s Board of Directors now consists of five members, four of whom are women.
Ms. Quanbeck brings to the board a deep passion and relevant experience with consumer products. She spent the first half of her career in public accounting and investment banking, including seven years at Bank of America Merrill Lynch in the retail, apparel and footwear industry, working on mergers and acquisitions and public and private market transactions. After her career in banking, Ms. Quanbeck moved into the operational side, holding senior finance roles at Charlotte Russe and now the DTC footwear brand Rothy’s, where she is Chief Financial Officer and a member of the Rothy’s Board of Directors. Her responsibilities as CFO include finance, strategy, data and analytics, and consumer insights. At Rothy’s, she was instrumental in increasing the company’s valuation at $1 billion.
Ms. Quanbeck’s experience in growing new business concepts and scaling businesses globally makes her a valuable addition to GLO Pharma’s Board of Directors. “Dayna brings the best of both worlds to our Board of Directors: strong analytical skills combined with strategic acumen,” said GL Pharmaceutical President Scott Glen. “She is skilled not only in contributing to strategy development, but also has an innate ability to analyze businesses constructively to ensure growth and profitability. We are honored to have her join our start-up company as we enter in a phase of strong growth.
This appointment follows the launch of GLO Pharma’s first consumer brand, Ourself, in February 2022and the recent announcement of ourselves as President Vimla Black-Gupta’s role to include the CEO. We are supported by $40 million in funding to date from investors such as Lightspeed Venture Partners, First Round Capital and Mr. Glenn.
Factory PR // Liz Hill
About GL Pharmacy :
GLO Pharma is a biotechnology company dedicated to developing innovative approaches to beauty and aesthetics. It was founded in 2018 by Scott Glen and Lauren Otsuki, biotech innovators for over 20 years. Mr. Glenn and Ms. Otsuki previously founded and developed the professional skin care companies Alastin Skincare and SkinMedica, as well as numerous pharmaceutical companies aimed at solving some of the most challenging medical issues in infertility, diabetes, cardiovascular disease and cancer. In 2022, GL Pharma launched its first consumer brand, Ourself, as the first-ever Subtopical Skincare System™, bridging the gap between traditional skincare products and clinical procedures through the use of biotechnology.
SOURCE GLO Pharma